Myocardin-related transcription factor A and Yes-associated protein exert dual control in G protein-coupled receptor- and RhoA-mediated transcriptional regulation and cell proliferation

Molecular and Cellular Biology

Volumn 36, Issue 1, 2016, Pages 39-49

  Yu, Olivia M ^a,b   Miyamoto, Shigeki ^a   Brown, Joan Heller ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYSTEINE RICH PROTEIN 61; G PROTEIN COUPLED RECEPTOR; MYOCARDIN RELATED TRANSCRIPTION FACTOR A; PEPTIDES AND PROTEINS; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN; SPHINGOSINE 1 PHOSPHATE; THROMBIN; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG; YES ASSOCIATED PROTEIN; MKL1 PROTEIN, HUMAN; PHOSPHOPROTEIN; SERUM RESPONSE FACTOR; SIGNAL TRANSDUCING ADAPTOR PROTEIN; TRANSACTIVATOR PROTEIN; YAP1 (YES-ASSOCIATED) PROTEIN, HUMAN;

ANIMAL CELL; ARTICLE; CELL PROLIFERATION; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; GENE EXPRESSION; GLIOBLASTOMA CELL LINE; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN PROTEIN INTERACTION; RAT; TRANSCRIPTION REGULATION; CELL CULTURE; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; GENETICS; METABOLISM; PHYSIOLOGY;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; CELL PROLIFERATION; CELLS, CULTURED; CYSTEINE-RICH PROTEIN 61; GENE EXPRESSION REGULATION; HUMANS; PHOSPHOPROTEINS; PROMOTER REGIONS, GENETIC; RECEPTORS, G-PROTEIN-COUPLED; RHOA GTP-BINDING PROTEIN; SERUM RESPONSE FACTOR; TRANS-ACTIVATORS; TRANSCRIPTION, GENETIC;

EID: 84954160508     PISSN: 02707306     EISSN: 10985549     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Aragay AM, Collins LR, Post GR, Watson AJ, Feramisco JR, Brown JH, Simon MI. 1995. G12 requirement for thrombin-stimulated gene expression and DNA synthesis in 1321N1 astrocytoma cells. J Biol Chem 270:20073-20077. http://dx.doi.org/10.1074/jbc.270.34.20073.
2. Post GR, Collins LR, Kennedy ED, Moskowitz SA, Aragay AM, Goldstein D, Brown JH. 1996. Coupling of the thrombin receptor to G12 may account for selective effects of thrombin on gene expression and DNA synthesis in 1321N1 astrocytoma cells. Mol Biol Cell 7:1679-1690. http://dx.doi.org/10.1091/mbc.7.11.1679.
3. Walsh CT, Radeff-Huang J, Matteo R, Hsiao A, Subramaniam S, Stupack D, Brown JH. 2008. Thrombin receptor and RhoA mediate cell proliferation through integrins and cysteine-rich protein 61. FASEB J 22:4011-4021. http://dx.doi.org/10.1096/fj.08-113266.
4. Ridley AJ, Hall A. 1992. The small GTP-binding protein rho regulates the assembly of focal adhesions and actin stress fibers in response to growth factors. Cell 70:389-399. http://dx.doi.org/10.1016/0092-8674(92)90163-7.
5. Mutoh T, Rivera R, Chun J. 2012. Insights into the pharmacological relevance of lysophospholipid receptors. Br J Pharmacol 165:829-844. http://dx.doi.org/10.1111/j.1476-5381.2011.01622.x.
6. Seasholtz TM, Radeff-Huang J, Sagi SA, Matteo R, Weems JM, Cohen AS, Feramisco JR, Brown JH. 2004. Rho-mediated cytoskeletal rearrangement in response to LPA is functionally antagonized by Rac1 and PIP2. J Neurochem 91:501-512. http://dx.doi.org/10.1111/j.1471-4159.2004.02749.x.
7. Lockman K, Hinson JS, Medlin MD, Morris D, Taylor JM, Mack CP. 2004. Sphingosine 1-phosphate stimulates smooth muscle cell differentiation and proliferation by activating separate serum response factor cofactors. J Biol Chem 279:42422-42430. http://dx.doi.org/10.1074/jbc.M405432200.
8. Han JS, Macarak E, Rosenbloom J, Chung KC, Chaqour B. 2003. Regulation of Cyr61/CCN1 gene expression through RhoA GTPase and p38MAPK signaling pathways. Eur J Biochem 270:3408-3421. http://dx.doi.org/10.1046/j.1432-1033.2003.03723.x.
9. Hilfiker-Kleiner D, Kaminski K, Kaminska A, Fuchs M, Klein G, Podewski E, Grote K, Kiian I, Wollert KC, Hilfiker A, Drexler H. 2004. Regulation of proangiogenic factor CCN1 in cardiac muscle: impact of ischemia, pressure overload, and neurohumoral activation. Circulation 109:2227-2233. http://dx.doi.org/10.1161/01.CIR.0000127952.90508.9D.
10. Young N, Pearl DK, Van Brocklyn JR. 2009. Sphingosine-1-phosphate regulates glioblastoma cell invasiveness through the urokinase plasminogen activator system and CCN1/Cyr61. Mol Cancer Res 7:23-32. http://dx.doi.org/10.1158/1541-7786.MCR-08-0061.
11. Jun JI, Lau LF. 2011. Taking aim at the extracellular matrix: CCN proteins as emerging therapeutic targets. Nat Rev Drug Discov 10:945-963. http://dx.doi.org/10.1038/nrd3599.
12. Lau LF. 2011. CCN1/CYR61: the very model of a modern matricellular protein. Cell Mol Life Sci 68:3149-3163. http://dx.doi.org/10.1007/s00018-011-0778-3.
13. Menendez JA, Vellon L, Mehmi I, Teng PK, Griggs DW, Lupu R. 2005. A novel CYR61-triggered 'CYR61-alphavbeta3 integrin loop' regulates breast cancer cell survival and chemosensitivity through activation of ERK1/ERK2 MAPK signaling pathway. Oncogene 24:761-779. http://dx.doi.org/10.1038/sj.onc.1208238.
14. Yu OM, Brown JH. 2015. G protein-coupled receptor and RhoA-stimulated transcriptional responses: links to inflammation, differentiation, and cell proliferation. Mol Pharmacol 88:171-180. http://dx.doi.org/10.1124/mol.115.097857.
15. Hill CS, Wynne J, Treisman R. 1995. The Rho family GTPases RhoA, Rac1, and CDC42Hs regulate transcriptional activation by SRF. Cell 81:1159-1170. http://dx.doi.org/10.1016/S0092-8674(05)80020-0.
16. Sahai E, Alberts AS, Treisman R. 1998. RhoA effector mutants reveal distinct effector pathways for cytoskeletal reorganization, SRF activation and transformation. EMBOJ 17:1350-1361. http://dx.doi.org/10.1093/emboj/17.5.1350.
17. Cen B, Selvaraj A, Burgess RC, Hitzler JK, Ma Z, Morris SW, Prywes R. 2003. Megakaryoblastic leukemia 1, a potent transcriptional coactivator for serum response factor (SRF), is required for serum induction of SRF target genes. Mol Cell Biol 23:6597-6608. http://dx.doi.org/10.1128/MCB.23.18.6597-6608.2003.
18. Miralles F, Posern G, Zaromytidou AI, Treisman R. 2003. Actin dynamics control SRF activity by regulation of its coactivator MAL. Cell 113:329-342. http://dx.doi.org/10.1016/S0092-8674(03)00278-2.
19. Cen B, Selvaraj A, Prywes R. 2004. Myocardin/MKL family of SRF coactivators: key regulators of immediate early and muscle specific gene expression. J Cell Biochem 93:74-82. http://dx.doi.org/10.1002/jcb.20199.
20. Guettler S, Vartiainen MK, Miralles F, Larijani B, Treisman R. 2008. RPEL motifs link the serum response factor cofactor MAL but not myocardin to Rho signaling via actin binding. Mol Cell Biol 28:732-742. http://dx.doi.org/10.1128/MCB.01623-07.
21. Baarlink C, Wang H, Grosse R. 2013. Nuclear actin network assembly by formins regulates the SRF coactivator MAL. Science 340:864-867. http://dx.doi.org/10.1126/science.1235038.
22. Rajakyla EK, Viita T, Kyheroinen S, Huet G, Treisman R, Vartiainen MK. 2015. RNA export factor Ddx19 is required for nuclear import of the SRF coactivator MKL1. Nat Commun 6:5978. http://dx.doi.org/10.1038/ncomms6978.
23. Vartiainen MK, Guettler S, Larijani B, Treisman R. 2007. Nuclear actin regulates dynamic subcellular localization and activity of the SRF cofactor MAL. Science 316:1749-1752. http://dx.doi.org/10.1126/science.1141084.
24. Evelyn CR, Wade SM, Wang Q, Wu M, Iniguez-Lluhi JA, Merajver SD, Neubig RR. 2007. CCG-1423: a small-molecule inhibitor of RhoA transcriptional signaling. Mol Cancer Ther 6:2249-2260. http://dx.doi.org/10.1158/1535-7163.MCT-06-0782.
25. Zhao X, Ding EY, Yu OM, Xiang SY, Tan-Sah VP, Yung BS, Hedgpeth J, Neubig RR, Lau LF, Brown JH, Miyamoto S. 2014. Induction of the matricellular protein CCN1 through RhoA and MRTF-A contributes to ischemic cardioprotection. J Mol Cell Cardiol 75C:152-161. http://dx.doi.org/10.1016/j.yjmcc.2014.07.017.
26. Feng X, Degese MS, Iglesias-Bartolome R, Vaque JP, Molinolo AA, Rodrigues M, Zaidi MR, Ksander BR, Merlino G, Sodhi A, Chen Q, Gutkind JS. 2014. Hippo-independent activation of YAP by the GNAQ uveal melanoma oncogene through a trio-regulated rho GTPase signaling circuitry. Cancer Cell 25:831-845. http://dx.doi.org/10.1016/j.ccr.2014.04.016.
27. Mo JS, Yu FX, Gong R, Brown JH, Guan KL. 2012. Regulation of the Hippo-YAP pathway by protease-activated receptors (PARs). Genes Dev 26:2138-2143. http://dx.doi.org/10.1101/gad.197582.112.
28. Yu FX, Luo J, Mo JS, Liu G, Kim YC, Meng Z, Zhao L, Peyman G, Ouyang H, Jiang W, Zhao J, Chen X, Zhang L, Wang CY, Bastian BC, Zhang K, Guan KL. 2014. Mutant Gq/11 promote uveal melanoma tumorigenesis by activating YAP. Cancer Cell 25:822-830. http://dx.doi.org/10.1016/j.ccr.2014.04.017.
29. Yu FX, Zhao B, Panupinthu N, Jewell JL, Lian I, Wang LH, Zhao J, Yuan H, Tumaneng K, Li H, Fu XD, Mills GB, Guan KL. 2012. Regulation of the Hippo-YAP pathway by G-protein-coupled receptor signaling. Cell 150:780-791. http://dx.doi.org/10.1016/j.cell.2012.06.037.
30. Aragona M, Panciera T, Manfrin A, Giulitti S, Michielin F, Elvassore N, Dupont S, Piccolo S. 2013. A mechanical checkpoint controls multicellular growth through YAP/TAZ regulation by actin-processing factors. Cell 154:1047-1059. http://dx.doi.org/10.1016/j.cell.2013.07.042.
31. Dupont S, Morsut L, Aragona M, Enzo E, Giulitti S, Cordenonsi M, Zanconato F, Le Digabel J, Forcato M, Bicciato S, Elvassore N, Piccolo S. 2011. Role of YAP/TAZ in mechanotransduction. Nature 474:179-183. http://dx.doi.org/10.1038/nature10137.
32. Zhao B, Ye X, Yu J, Li L, Li W, Li S, Lin JD, Wang CY, Chinnaiyan AM, Lai ZC, Guan KL. 2008. TEAD mediates YAP-dependent gene induction and growth control. Genes Dev 22:1962-1971. http://dx.doi.org/10.1101/gad.1664408.
33. Zhao B, Kim J, Ye X, Lai ZC, Guan KL. 2009. Both TEAD-binding and WW domains are required for the growth stimulation and oncogenic transformation activity of Yes-associated protein. Cancer Res 69:1089-1098. http://dx.doi.org/10.1158/0008-5472.CAN-08-2997.
34. Hanna M, Liu H, Amir J, Sun Y, Morris SW, Siddiqui MA, Lau LF, Chaqour B. 2009. Mechanical regulation of the proangiogenic factor CCN1/CYR61 gene requires the combined activities of MRTF-A and CREB-binding protein histone acetyltransferase. J Biol Chem 284:23125-23136. http://dx.doi.org/10.1074/jbc.M109.019059.
35. Schmittgen TD, Livak KJ. 2008. Analyzing real-time PCR data by the comparative C(T) method. Nat Protoc 3:1101-1108. http://dx.doi.org/10.1038/nprot.2008.73.
36. Hwang SM, Jin M, Shin YH, Ki Choi S, Namkoong E, Kim M, Park MY, Park K. 2014. Role of LPA and the Hippo pathway on apoptosis in salivary gland epithelial cells. Exp Mol Med 46:e125. http://dx.doi.org/10.1038/emm.2014.77.
37. Haak AJ, Tsou PS, Amin MA, Ruth JH, Campbell P, Fox DA, Khanna D, Larsen SD, Neubig RR. 2014. Targeting the myofibroblast genetic switch: inhibitors of myocardin-related transcription factor/serum response factor-regulated gene transcription prevent fibrosis in a murine model of skin injury. J Pharmacol Exp Ther 349:480-486. http://dx.doi.org/10.1124/jpet.114.213520.
38. Small EM, Thatcher JE, Sutherland LB, Kinoshita H, Gerard RD, Richardson JA, Dimaio JM, Sadek H, Kuwahara K, Olson EN. 2010. Myocardin-related transcription factor-A controls myofibroblast activation and fibrosis in response to myocardial infarction. Circ Res 107:294-304. http://dx.doi.org/10.1161/CIRCRESAHA.110.223172.
39. Liu F, Wang X, Hu G, Wang Y, Zhou J. 2014. The transcription factor TEAD1 represses smooth muscle-specific gene expression by abolishing myocardin function. J Biol Chem 289:3308-3316. http://dx.doi.org/10.1074/jbc.M113.515817.
40. Xie C, Guo Y, Zhu T, Zhang J, Ma PX, Chen YE. 2012. Yap1 protein regulates vascular smooth muscle cell phenotypic switch by interaction with myocardin. J Biol Chem 287:14598-14605. http://dx.doi.org/10.1074/jbc.M111.329268.
41. Esnault C, Stewart A, Gualdrini F, East P, Horswell S, Matthews N, Treisman R. 2014. Rho-actin signaling to the MRTF coactivators dominates the immediate transcriptional response to serum in fibroblasts. Genes Dev 28:943-958. http://dx.doi.org/10.1101/gad.239327.114.
42. Hinson JS, Medlin MD, Lockman K, Taylor JM, Mack CP. 2007. Smooth muscle cell-specific transcription is regulated by nuclear localization of the myocardin-related transcription factors. Am J Physiol Heart Circ Physiol 292:H1170-H1180. http://dx.doi.org/10.1152/ajpheart.00864.2006.